James E. Flynn 13D and 13G filings for GeneDx Holdings Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-01 5:11 pm Purchase | 2023-01-31 | 13G | GeneDx Holdings Corp. WGS | James E. Flynn | 1,733,094 7.260% | 1,161,928 (+203.43%) | Filing |
| 2022-08-17 1:11 pm Purchase | 2022-08-17 | 13G | GeneDx Holdings Corp. WGS | James E. Flynn | 571,166 4.950% | 147,929 (+34.95%) | Filing |
| 2022-02-11 4:16 pm Purchase | 2021-12-31 | 13G | GeneDx Holdings Corp. WGS | James E. Flynn | 423,237 5.790% | 3,586 (+0.85%) | Filing |
| 2021-08-02 12:56 pm Purchase | 2021-07-22 | 13G | GeneDx Holdings Corp. WGS | James E. Flynn | 419,651 5.770% | 419,651 (New Position) | Filing |